|
1
|
Bateman RJ, Aschenbrenner AJ, Benzinger TL, Clifford D, Coalier K, Cruchaga C, Fagan AM, Farlow MR, Goate AM, Gordon BA, Hassenstab J, Jack CR, Koeppe RA, McDade E, Mills S, Morris JC, Salloway SP, Santacruz A, Snyder PJ, Wang G, Xiong C, Snider BJ, Mummery CJ, Surti GM, Hannequin D, Wallon D, Berman S, Lah JJ, Jiménez‐Velazquez IZ, Roberson ED, Dyck CH, Honig LS, Sanchez‐Valle R, Brooks WS, Gauthier S, Masters CL, Galasko DR, Brosch JR, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Andersen SW, Holdridge KC, Mintun MA, Sims JR, Yaari R, Baudler M, Delmar P, Doody R, Fontoura P, Kerchner GA. Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab. Alzheimers Dement 2020. [DOI: 10.1002/alz.041129] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Randall J Bateman
- Washington University in St. Louis School of Medicine St. Louis MO USA
| | | | | | - David Clifford
- Washington University in St. Louis School of Medicine St. Louis MO USA
| | | | - Carlos Cruchaga
- Hope Center for Neurological Disorders Washington University School of Medicine St. Louis MO USA
| | - Anne M. Fagan
- Washington University School of Medicine St. Louis MO USA
| | - Martin R. Farlow
- Department of Neurology Indiana University School of Medicine Indianapolis IN USA
| | - Alison M. Goate
- Ronald M. Loeb Center for Alzheimer’s Disease New York NY USA
| | | | - Jason Hassenstab
- Washington University in St. Louis School of Medicine St. Louis MO USA
| | | | | | - Eric McDade
- Knight Alzheimer Disease Research Center St. Louis MO USA
| | - Susan Mills
- Washington University in St. Louis School of Medicine St. Louis MO USA
| | - John C. Morris
- Knight Alzheimer Disease Research Center St. Louis MO USA
| | | | - Anna Santacruz
- Washington University in St. Louis School of Medicine St. Louis MO USA
| | | | - Guoqiao Wang
- Washington University in St. Louis School of Medicine St. Louis MO USA
| | - Chengjie Xiong
- Washington University in St. Louis School of Medicine St. Louis MO USA
| | | | | | | | | | | | - Sarah Berman
- University of Pittsburgh School of Medicine Pittsburgh PA USA
| | - James J. Lah
- Emory University School of Medicine Atlanta GA USA
| | | | | | | | | | | | | | - Serge Gauthier
- McGill University Research Centre for Studies in Aging Montreal QC Canada
| | - Colin L. Masters
- The Florey Institute of Neuroscience and Mental Health, Melbourne VIC Australia
| | | | | | | | | | | | - Mario Masellis
- Hurvitz Brain Sciences Program Sunnybrook Research Institute Toronto ON Canada
| | | | | | - Bruno Dubois
- Institute of Memory and Alzheimer's Disease (IM2A) Department of Neurology Pitié‐Salpêtrière Hospital, AP‐HP, l'Hôpital Paris France
| | | | | | | | | | | | - Roy Yaari
- Eli Lilly and Company Indianapolis IN USA
| | - Monika Baudler
- Roche/Genentech Product Development, Neuroscience Basel Switzerland
| | | | - Rachelle Doody
- Roche Pharma Research and Early Development Basel Switzerland
| | - Paulo Fontoura
- Roche/Genentech Product Development, Neuroscience Basel Switzerland
| | | | | |
Collapse
|
|
2
|
Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Gallezot JD, McDonald JW, Michalak HR, Nabulsi NB, Huang Y, Arnsten AF, Carson RE, Dyck CH. P2‐365: PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A) IN ALZHEIMER'S DISEASE: INITIAL EXPERIENCE. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.1056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
|
3
|
Mecca AP, McDonald JW, Michalak HR, Godek T, Harris J, Chen MK, Nabulsi NB, Salardini A, Carson RE, Strittmatter SM, Dyck CH. IC‐04‐03: PET IMAGING OF METABOTROPIC GLUTAMATE RECEPTOR 5 BINDING IN ALZHEIMER'S DISEASE. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.2051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
|
4
|
Arnsten AF, Carlyle BC, Leslie S, Preuss TM, Crimins JL, Datta D, Anita HJ, Dyck CH, Rosene DL, Nairn AC, Paspalas C. P3‐088: THE AGING RHESUS MONKEY IS AN APPROPRIATE NEW ANIMAL MODEL FOR STUDYING THE ETIOLOGY AND TREATMENT OF TAU PATHOLOGY IN ASSOCIATION CORTEX. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.1444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
| | - Becky C. Carlyle
- Massachusetts General HospitalHarvard Medical SchoolCharlestownMAUSA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
|
5
|
Egan MF, Voss T, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Dyck CH, Sur C, Mukai Y, Furtek C, Mahoney EM, Mozley LH, Mo Y, Michelson D. P4‐013: DESIGN OF A PHASE‐3 TRIAL (APECS) TO EVALUATE THE BACE INHIBITOR VERUBECESTAT IN PRODROMAL AD. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.2415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
| | | | | | | | | | | | - Bruno Vellas
- Gerontopole, INSERM U, Alzheimer's Disease Research and Clinical CenterToulouse University HospitalToulouseFrance
| | | | | | | | | | | | | | - Yi Mo
- Merck & Co. Inc.KenilworthNJUSA
| | | |
Collapse
|
|
6
|
Mecca AP, Chen MK, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, Gallezot JD, McDonald JW, Michalak HR, Nabulsi NB, Huang Y, Arnsten AF, Carson RE, Dyck CH. IC‐P‐183: PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A) IN ALZHEIMER'S DISEASE: INITIAL EXPERIENCE. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.2250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
|
7
|
Carlyle BC, Leslie S, Trombetta BA, Nobuhara CK, Dyck CH, Nairn AC, Arnold SE. P1‐274: A TARGETED MASS‐SPECTROMETRY METHOD FOR QUANTIFICATION OF CEREBROSPINAL FLUID BIOMARKERS OF ALZHEIMER'S DISEASE. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Becky C. Carlyle
- Massachusetts General HospitalHarvard Medical SchoolCharlestownMAUSA
| | | | | | - Chloe K. Nobuhara
- Massachusetts General HospitalHarvard Medical SchoolCharlestownMAUSA
| | | | | | - Steven E. Arnold
- Massachusetts General HospitalHarvard Medical SchoolCharlestownMAUSA
| |
Collapse
|
|
8
|
Johnson KA, Schultz AP, Raman R, Donohue MC, Sun CK, Jacobs HIL, Marek K, Seibyl J, Mintun MA, Shcherbinin S, Pontecorvo MJ, Mormino BC, Rowe CC, Dyck CH, Salloway S, Jack CR, Yaari R, Holdridge KC, Aisen PS, Sperling RA. P4‐321: TAU PET IN A4: PRELIMINARY REPORT. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.07.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Keith A. Johnson
- Department of Radiology, Division of Molecular Imaging and Nuclear MedicineMassachusetts General HospitalBostonMAUSA
| | | | - Rema Raman
- University of Southern CaliforniaSan DiegoCAUSA
| | | | | | - Heidi IL. Jacobs
- Alzheimer Center LimburgMaastricht UniversityMaastrichtNetherlands
| | - Kenneth Marek
- Molecular NeuroimagingA Division of inviCRONew HavenCTUSA
| | | | | | | | | | | | | | | | | | | | - Roy Yaari
- Lilly Research LaboratoriesIndianapolisINUSA
| | | | - Paul S. Aisen
- Alzheimer's Therapeutic Research InstituteSan DiegoCAUSA
| | - Reisa A. Sperling
- Center for Alzheimer Research and Treatment, Brigham and Women's HospitalHarvard Medical SchoolBostonMAUSA
| |
Collapse
|
|
9
|
Dyck CH, Mecca AP, Wang S, Barcelos NM, Planeta-Wilson B, Gelernter J, Ness P, Carson RE. IC‐P‐101: Amyloid burden is associated with decreased gray matter volume but not episodic memory performance in cognitively normal first‐degree relatives at varying ApoE4 risk for Alzheimer's disease. Alzheimers Dement 2015. [DOI: 10.1016/j.jalz.2015.06.123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
| | | | - Shuo Wang
- Yale University School of MedicineNew HavenCTUSA
| | | | | | | | - Peter Ness
- Yale University School of MedicineNew HavenCTUSA
| | | |
Collapse
|
|
10
|
Dyck CH, Barcelos N, Brück A, Planeta‐Wilson B, Gelernter J, Carson R. IC‐O1‐03: Amyloid burden and neuropsychological performance in presymptomatic first‐degree relatives at varying APOE‐ɛ4 risk for Alzheimer's disease. Alzheimers Dement 2012. [DOI: 10.1016/j.jalz.2012.05.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
| | - Nicole Barcelos
- Yale University School of MedicineNew HavenConnecticutUnited States
| | | | | | - Joel Gelernter
- Yale University School of MedicineNew HavenConnecticutUnited States
| | - Richard Carson
- Yale University School of MedicineNew HavenConnecticutUnited States
| |
Collapse
|
|
11
|
Farlow M, Arnold SE, Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER. Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimers Dement 2012; 8:261-71. [DOI: 10.1016/j.jalz.2011.09.224] [Citation(s) in RCA: 171] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2010] [Revised: 08/03/2011] [Accepted: 09/14/2011] [Indexed: 10/28/2022]
Affiliation(s)
- Martin Farlow
- Department of NeurologyIndiana University School of MedicineIndianapolisINUSA
| | - Steven E. Arnold
- Penn Memory CenterUniversity of PennsylvaniaPhiladelphiaPAUSA
- Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaPAUSA
- Department of NeurologyUniversity of PennsylvaniaPhiladelphiaPAUSA
| | - Christopher H. Dyck
- Department of PsychiatryYale University School of MedicineNew HavenCTUSA
- Department of NeurobiologyYale University School of MedicineNew HavenCTUSA
| | - Paul S. Aisen
- Department of NeurosciencesUniversity of California San DiegoLa JollaCAUSA
| | - B. Joy Snider
- Department of NeurologyWashington University School of MedicineSt. LouisMOUSA
| | - Anton P. Porsteinsson
- Alzheimer's Disease Care, Research and Education (AD‐CARE) Program, Department of PsychiatryUniversity Rochester School of Medicine and DentistryRochesterNYUSA
| | - Stuart Friedrich
- Lilly Research LaboratoriesEli Lilly and CompanyIndianapolisINUSA
| | - Robert A. Dean
- Lilly Research LaboratoriesEli Lilly and CompanyIndianapolisINUSA
| | - Celedon Gonzales
- Lilly Research LaboratoriesEli Lilly and CompanyIndianapolisINUSA
| | | | | | - Richard Mohs
- Lilly Research LaboratoriesEli Lilly and CompanyIndianapolisINUSA
| | - Steven M. Paul
- Appel Alzheimer's Disease Research InstituteWeill Cornell Medical CollegeNew YorkNYUSA
| | - Eric R. Siemers
- Lilly Research LaboratoriesEli Lilly and CompanyIndianapolisINUSA
| |
Collapse
|
|
12
|
Dyck CH. Neuroimaging in Alzheimer's Disease: Relevance for the Development of Therapeutic Agents. CNS Drug Reviews 2006. [DOI: 10.1111/j.1527-3458.2000.tb00172.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
|
13
|
Petersen RC, Thomas RG, Grundman M, Bennett DA, Kaye J, Levey AI, Pfeiffer E, Sano M, Dyck CH, Thal LJ. [O1‐04‐04]: Operational criteria for patient recruitment in trials of mild cognitive impairment. Alzheimers Dement 2005. [DOI: 10.1016/j.jalz.2005.06.303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
| | | | | | | | - Jeffrey Kaye
- Oregon Health And Science UniversityPortlandORUSA
| | | | - Eric Pfeiffer
- University of South Florida College of MedicineTampaFLUSA
| | - Mary Sano
- Mount Sinai School of MedicineNew YorkNYUSA
| | | | - Leon J. Thal
- University of California at San DiegoSan DiegoCAUSA
| |
Collapse
|